Principles for correcting lipid metal disorders in women with climacteric syndrome

One of the important pathogenetic reasons for the increase in the number of women in the perimenopausal period with the development of climacteric syndrome (CS) is dyslipidemic disorders. Determining the place of statins in HRT will allow solving the problem of maintaining the health of women of perimenopausal age. On the basis of a study of 40 women, results were obtained that give grounds to consider the use of simvastatin in the complex treatment of climacteric syndrome advisable.